Rasburicase

ब्रांड नाम

Nepal brand names not included: no licence-safe source.

What it is used for

Elitek is indicated for the initial management of plasma uric acid levels in pediatric and adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anticancer therapy expected to result in tumor lysis and subsequent elevation of plasma uric acid.

How it works

In humans, uric acid is the final step in the catabolic pathway of purines. Rasburicase catalyzes enzymatic oxidation of poorly soluble uric acid into an inactive and more soluble metabolite (allantoin).

Common side effects

The following clinically significant adverse reactions are discussed in greater detail in other sections of the prescribing information: Anaphylaxis Hemolysis Methemoglobinemia Most common adverse reactions (incidence ≥20%), when used concomitantly with anticancer therapy are vomiting, nausea, fever, peripheral edema, anxiety, headache, abdominal...

Do not use if (contraindications)

Elitek is contraindicated in patients with a history of anaphylaxis or severe hypersensitivity to rasburicase or in patients with development of hemolytic reactions or methemoglobinemia with rasburicase.

Pregnancy & breastfeeding

Pregnancy (label summary): Risk Summary Based on findings in animals, Elitek may cause fetal harm when administered to pregnant women. The limited available data with Elitek use in pregnant women are insufficient to inform a drug-associated risk of major birth defects, miscarriage, or adverse maternal fetal outcomes.

सामान्य प्रश्न

What is Rasburicase used for?
Elitek is indicated for the initial management of plasma uric acid levels in pediatric and adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anticancer therapy expected to result in tumor lysis and subsequent elevation of plasma uric acid.

How does Rasburicase work?
In humans, uric acid is the final step in the catabolic pathway of purines. Rasburicase catalyzes enzymatic oxidation of poorly soluble uric acid into an inactive and more soluble metabolite (allantoin).

What are the side effects of Rasburicase?
The following clinically significant adverse reactions are discussed in greater detail in other sections of the prescribing information: Anaphylaxis Hemolysis Methemoglobinemia Most common adverse reactions (incidence ≥20%), when used concomitantly with anticancer therapy are vomiting, nausea, fever, peripheral edema,...

Who should not take Rasburicase?
Elitek is contraindicated in patients with a history of anaphylaxis or severe hypersensitivity to rasburicase or in patients with development of hemolytic reactions or methemoglobinemia with rasburicase.

Does Rasburicase have a boxed warning?
HYPERSENSITIVITY REACTIONS, HEMOLYSIS, METHEMOGLOBINEMIA, AND INTERFERENCE WITH URIC ACID MEASUREMENTS WARNING: HYPERSENSITIVITY REACTIONS, HEMOLYSIS, METHEMOGLOBINEMIA, AND INTERFERENCE WITH URIC ACID MEASUREMENTS See full prescribing information for complete boxed warning.

Can I take Rasburicase in pregnancy or while breastfeeding?
Pregnancy (label summary): Risk Summary Based on findings in animals, Elitek may cause fetal harm when administered to pregnant women. The limited available data with Elitek use in pregnant women are insufficient to inform a drug-associated risk of major birth defects, miscarriage, or adverse maternal fetal outcomes.

What is the dose of Rasburicase?
Not provided here. Ask a doctor or pharmacist.

Rasburicase क्या है?
Rasburicase is used for: Elitek is indicated for the initial management of plasma uric acid levels in pediatric and adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anticancer therapy expected to result in tumor lysis and subsequent elevation of plasma uric acid. Common side eff…